The latest news from Chinese pharma, including an examination of the new national reimbursement drug list (NRDL), the therapies that have and have not…
Speaking exclusively to PharmaBoardroom, Jan van de Winkel highlights the tremendous progress that European biotech success story Genmab has made over…